Physician profile
Felix Hernandez
NPI 1518072529
$542.58
in general payments reported to CMS, 2019-2025
11 companies · $71.32 in 2025
The $71.32 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $239 · 2024: $232 · 2025: $71.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $108.83 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $100.10 | 2023-2024 | |
| Amgen INC. | $75.89 | 2023-2024 | Repatha |
| Endologix LLC | $59.78 | 2024 | Torus Stent Graft System, Endocross Device |
| Astrazeneca Pharmaceuticals LP | $41.87 | 2023-2024 | Farxiga, Wainua |
| Merck Sharp & Dohme LLC | $38.39 | 2023-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $37.59 | 2023-2024 | Amvuttra |
| Lantheus Medical Imaging, INC. | $32.01 | 2023 | Definity |
| Daiichi Sankyo INC. | $18.53 | 2024 | Injectafer |
| Kiniksa Pharmaceuticals International, Plc | $15.23 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $14.36 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felix Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.